Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6

Authors:
  • SYShan-Shan Yu
    Shan-Shan Yu
  • SCShao-Rui Chen
    Shao-Rui Chen
  • RPRong-Biao Pi
    Rong-Biao Pi
  • SGSi Gao
    Si Gao
  • HLHong Li
    Hong Li
  • JYJian-Tao Ye
    Jian-Tao Ye

Abstract
The discovery of sirtuins (SIRT), a family of nicotinamide adenine dinucleotide (NAD)‐dependent deacetylases, has indicated that intracellular NAD level is crucial for the hypertrophic response of cardiomyocytes. Nicotinamide mononucleotide adenylyltransferase (Nmnat) is a central enzyme in NAD biosynthesis. Here we revealed that Nmnat2 protein expression and enzyme activity were down‐regulated during cardiac hypertrophy. In neonatal rat cardiomyocytes, overexpression of Nmnat2 but not its catalytically inactive mutant blocked angiotensin II (Ang II)‐induced cardiac hypertrophy, which was dependent on activation of SIRT6 through maintaining the intracellular NAD level. Our results suggested that modulation of Nmnat2 activity may be beneficial in cardiac hypertrophy.

This publication has 34 references indexed in Scilit: